Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adenine Dinucleotide, Dihydronicotinamide
2. Coenzyme I
3. Dihydronicotinamide Adenine Dinucleotide
4. Dinucleotide, Dihydronicotinamide Adenine
5. Dinucleotide, Nicotinamide-adenine
6. Diphosphopyridine Nucleotide
7. Dpn
8. Nad
9. Nadh
10. Nadide
11. Nicotinamide Adenine Dinucleotide
12. Nicotinamide-adenine Dinucleotide
13. Nucleotide, Diphosphopyridine
1. Nicotinamide Adenine Dinucleotide
2. Nad+
3. Enzopride
4. Diphosphopyridine Nucleotide
5. 53-84-9
6. Adenine-nicotinamide Dinucleotide
7. Nad
8. Nadidum [inn-latin]
9. Nadida [inn-spanish]
10. Nad(+)
11. Chebi:15846
12. [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl Hydrogen Phosphate
13. 151411-04-0
14. Nicotinamide-adenine Dinucleotide
15. Brn 3584133
16. Sr-05000001677
17. Nadide [usan:ban:inn:jan]
18. Nad Cation
19. [[(2r,3s,4r,5r)-5-[(3r)-3-aminocarbonyl-3,4-dihydro-2h-pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl Phosphate
20. 121053-11-0
21. Naj
22. Txe
23. Spectrum_000973
24. Nicotinamide Adenine Dinucleotide (nad+)
25. [[(2~{r},3~{s},4~{r},5~{r})-5-(3-aminocarbonylpyridin-1-ium-1-yl)-4-[[5-[4-cyano-2-[(~{e})-hydroxyiminomethyl]phenoxy]-1-oxidanyl-3~{h}-2,1$l^{4}-benzoxaborol-1-yl]oxy]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{r},3~{s},4~{r},5~{r})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl Hydrogen Phosphate
26. 9jm
27. Adenosine 5'-(trihydrogen Diphosphate), P'-5'-ester With 3-(aminocarbonyl)-1-beta-d-ribofuranosylpyridinium, Inner Salt
28. Prestwick3_000741
29. Pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, Hydroxide, 5'-ester With Adenosine 5'-5'-(trihydrogen Pyrophosphate), Inner Salt
30. Spectrum2_001056
31. Spectrum3_000511
32. Spectrum4_000065
33. Spectrum5_001291
34. Bmse000053
35. Nadide (jan/usan/inn)
36. Bspbio_000722
37. Bspbio_002061
38. Kbiogr_000589
39. Kbioss_001453
40. Divk1c_000189
41. Spbio_001012
42. Bpbio1_000796
43. Chembl3039307
44. Schembl14478781
45. Kbio1_000189
46. Kbio2_001453
47. Kbio2_004021
48. Kbio2_006589
49. Kbio3_001561
50. Ninds_000189
51. Zinc8214766
52. Idi1_000189
53. 65085-09-8
54. C00003
55. D00002
56. 036d253
57. Sr-05000001677-1
58. Sr-05000001677-3
59. Brd-a11132253-001-01-7
60. Q26987253
61. 1-[5-o-[(5'-adenylyloxy)phosphonyl]-beta-d-ribofuranosyl]-3-(aminocarbonyl)pyridinium
62. Coconut Oil, Polymer With Benzoic Acid, Glycerol, Pentaerythritol And Phthalic Anhydride
63. 865-05-4
64. Adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-d-ribitol-5-yl] Dihydrogen Diphosphate}
Molecular Weight | 664.4 g/mol |
---|---|
Molecular Formula | C21H28N7O14P2+ |
XLogP3 | -5.9 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 11 |
Exact Mass | 664.11694759 g/mol |
Monoisotopic Mass | 664.11694759 g/mol |
Topological Polar Surface Area | 318 Ų |
Heavy Atom Count | 44 |
Formal Charge | 1 |
Complexity | 1130 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Beta Nicotinamide Adenine Dinucleotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beta Nicotinamide Adenine Dinucleotide, including repackagers and relabelers. The FDA regulates Beta Nicotinamide Adenine Dinucleotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beta Nicotinamide Adenine Dinucleotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Beta Nicotinamide Adenine Dinucleotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Beta Nicotinamide Adenine Dinucleotide supplier is an individual or a company that provides Beta Nicotinamide Adenine Dinucleotide active pharmaceutical ingredient (API) or Beta Nicotinamide Adenine Dinucleotide finished formulations upon request. The Beta Nicotinamide Adenine Dinucleotide suppliers may include Beta Nicotinamide Adenine Dinucleotide API manufacturers, exporters, distributors and traders.
click here to find a list of Beta Nicotinamide Adenine Dinucleotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Beta Nicotinamide Adenine Dinucleotide DMF (Drug Master File) is a document detailing the whole manufacturing process of Beta Nicotinamide Adenine Dinucleotide active pharmaceutical ingredient (API) in detail. Different forms of Beta Nicotinamide Adenine Dinucleotide DMFs exist exist since differing nations have different regulations, such as Beta Nicotinamide Adenine Dinucleotide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Beta Nicotinamide Adenine Dinucleotide DMF submitted to regulatory agencies in the US is known as a USDMF. Beta Nicotinamide Adenine Dinucleotide USDMF includes data on Beta Nicotinamide Adenine Dinucleotide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Beta Nicotinamide Adenine Dinucleotide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Beta Nicotinamide Adenine Dinucleotide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Beta Nicotinamide Adenine Dinucleotide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Beta Nicotinamide Adenine Dinucleotide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Beta Nicotinamide Adenine Dinucleotide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Beta Nicotinamide Adenine Dinucleotide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Beta Nicotinamide Adenine Dinucleotide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Beta Nicotinamide Adenine Dinucleotide suppliers with NDC on PharmaCompass.
Beta Nicotinamide Adenine Dinucleotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Beta Nicotinamide Adenine Dinucleotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Beta Nicotinamide Adenine Dinucleotide GMP manufacturer or Beta Nicotinamide Adenine Dinucleotide GMP API supplier for your needs.
A Beta Nicotinamide Adenine Dinucleotide CoA (Certificate of Analysis) is a formal document that attests to Beta Nicotinamide Adenine Dinucleotide's compliance with Beta Nicotinamide Adenine Dinucleotide specifications and serves as a tool for batch-level quality control.
Beta Nicotinamide Adenine Dinucleotide CoA mostly includes findings from lab analyses of a specific batch. For each Beta Nicotinamide Adenine Dinucleotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Beta Nicotinamide Adenine Dinucleotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Beta Nicotinamide Adenine Dinucleotide EP), Beta Nicotinamide Adenine Dinucleotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beta Nicotinamide Adenine Dinucleotide USP).
LOOKING FOR A SUPPLIER?